Table 1 -.
Subject Data.
Subject | Sex | Age (years) | Treatment Group | Lesion Hemisphere | Lesion Volume (mm3)* | Supplier |
---|---|---|---|---|---|---|
SM014j | M | 8.5 | Placebo | L | 87 | CPRC |
SM018j | M | 9.6 | Placebo | L | 84 | CPRC |
SM020j | M | 9.3 | Placebo | R | 123 | CPRC |
SM022j | M | 10.6 | Placebo | R | 59 | CPRC |
SM016j | M | 10.1 | hUTC Treated | L | 63 | CPRC |
SM017j | M | 8.6 | hUTC Treated | L | 58 | CPRC |
SM021j | M | 11.5 | hUTC Treated | R | 114 | CPRC |
SM024j | M | 12.1 | hUTC Treated | L | 106 | YNPRC |
Abbreviations: hUTC, human umbilical tissue derived cells (CNT00007, Advanced Technologies and Regenerative Medicine, LLC - merged with DePuy Orthopaedics, Inc on 30 December 2012 - Johnson & Johnson, New Brunswick, NJ). CPRC, Caribbean Primate Research Center, University of Puerto Rico, San Juan, PR. YNPRC, Yerkes National Primate Research Center, Emory University, Atlanta, GA.
Previously published data in Moore et al., 2013 (used in correlation studies in the current study)